e-Drug3D

1864

OZENOXACIN

DISCONTINUED

INN
OZENOXACIN

cas 245765-41-7

CLASS

DERMATOLOGICALS
ANTIBIOTICS
QUINOLONE
TOPICAL TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES

ROUTE (list)

TOPICAL

ATC code

D06AX14

PK parameters

PPB 82.5 PERCENT

Target

TARGET DNA GYRASE A
TOPOISOMERASE IV

Unknown

Download SDF file

3-Quinolinecarboxylic acid, 1-cyclopropyl-1,4-dihydro-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-

Formula:
C21H21N3O3

Calculated chemical properties:

MW 362.40
NB_atoms 27
XLogP 2.42
PSA 74.553
NB_HD 1
NB_HA 6
fsp3 0.29
Lipinski(0=no;1=yes) 1

FDA
NDA 208945 (label) INN (OZENOXACIN) XEPI (FERRER INTERNACIONAL) APPROVAL= AP YEAR= 2017 NEWMOLECULARENTITY DISCONTINUED